Loading company…
Meduloc develops minimally invasive implants for fixing small and long-bone fractures.
Founded in 2016 in California, Meduloc develops intramedullary implants for small and long-bone fractures, designed to provide rotational stability while limiting soft tissue disruption. Its applications include metacarpal, metatarsal, phalange, clavicle, radius, ulna, and fibula fractures. In July 2026, it raised USD 1.84 million in Series B funding led by GenHenn Capital, with participation from Life Sciences Greenhouse Investments, Ben Franklin Technology Partners, and Broad Street Angels.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in